{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T15:36:49Z","timestamp":1789832209578,"version":"4.0.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"41","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,19]],"date-time":"2016-08-19T00:00:00Z","timestamp":1471564800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.vaccine.2016.08.044","type":"journal-article","created":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T20:55:20Z","timestamp":1473454520000},"page":"4943-4947","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Safety profile of the varicella vaccine (Oka vaccine strain) based on reported cases from 2005 to 2015 in Japan"],"prefix":"10.1016","volume":"34","author":[{"given":"Tetsushi","family":"Yoshikawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Ando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Gomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7892","key":"10.1016\/j.vaccine.2016.08.044_b0005","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/S0140-6736(74)90144-5","article-title":"Live vaccine used to prevent the spread of varicella in children in hospital","volume":"2","author":"Takahashi","year":"1974","journal-title":"Lancet"},{"issue":"7978","key":"10.1016\/j.vaccine.2016.08.044_b0010","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0140-6736(76)92397-7","article-title":"Use of live varicella vaccine in children with acute leukaemia or other malignancies","volume":"2","author":"Hattori","year":"1976","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.vaccine.2016.08.044_b0015","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1542\/peds.60.6.805","article-title":"Application of a live varicella vaccine in children with acute leukemia or other malignant diseases","volume":"60","author":"Izawa","year":"1977","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.vaccine.2016.08.044_b0020","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1542\/peds.65.2.346","article-title":"Application of live varicella vaccine to children with acute leukemia or other malignancies without suspension of anticancer therapy","volume":"65","author":"Ha","year":"1980","journal-title":"Pediatrics"},{"issue":"4 Pt 1","key":"10.1016\/j.vaccine.2016.08.044_b0025","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1542\/peds.94.4.524","article-title":"Experience and reason: twenty-year follow-up of protective immunity of the Oka strain live varicella vaccine","volume":"94","author":"Asano","year":"1994","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.vaccine.2016.08.044_b0030","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jpeds.2003.10.025","article-title":"Reduction in pediatric hospitalizations for varicella-related invasive group A streptococcal infections in the varicella vaccine era","volume":"144","author":"Patel","year":"2004","journal-title":"J Pediatr"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2016.08.044_b0035","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1086\/522156","article-title":"Changing varicella epidemiology in active surveillance sites\u2013United States, 1995\u20132005","volume":"197","author":"Guris","year":"2008","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2016.08.044_b0040","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1542\/peds.2004-0012","article-title":"Decline in varicella-related hospitalizations and expenditures for children and adults after introduction of varicella vaccine in the United States","volume":"114","author":"Davis","year":"2004","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.vaccine.2016.08.044_b0045","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1056\/NEJMoa042271","article-title":"Decline in mortality due to varicella after implementation of varicella vaccination in the United States","volume":"352","author":"Nguyen","year":"2005","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.vaccine.2016.08.044_b0050","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1001\/jama.287.5.606","article-title":"Varicella disease after introduction of varicella vaccine in the United States, 1995\u20132000","volume":"287","author":"Seward","year":"2002","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.vaccine.2016.08.044_b0055","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s10156-013-0577-x","article-title":"Varicella vaccination in Japan: necessity of implementing a routine vaccination program","volume":"19","author":"Ozaki","year":"2013","journal-title":"J Infect Chemother"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2016.08.044_b0060","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1086\/522125","article-title":"The safety profile of varicella vaccine: a 10-year review","volume":"197","author":"Galea","year":"2008","journal-title":"J Infect Dis"},{"issue":"7\u20138","key":"10.1016\/j.vaccine.2016.08.044_b0065","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S0264-410X(00)00297-8","article-title":"The postmarketing safety profile of varicella vaccine","volume":"19","author":"Sharrar","year":"2000","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2016.08.044_b0070","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1001\/jama.284.10.1271","article-title":"Postlicensure safety surveillance for varicella vaccine","volume":"284","author":"Wise","year":"2000","journal-title":"JAMA"},{"issue":"36","key":"10.1016\/j.vaccine.2016.08.044_b0075","doi-asserted-by":"crossref","first-page":"5878","DOI":"10.1016\/j.vaccine.2010.06.056","article-title":"Safety profile of live varicella virus vaccine (Oka\/Merck): five-year results of the European Varicella Zoster Virus Identification Program (EU VZVIP)","volume":"28","author":"Goulleret","year":"2010","journal-title":"Vaccine"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2016.08.044_b0080","doi-asserted-by":"crossref","first-page":"S170","DOI":"10.1086\/522161","article-title":"Safety of varicella vaccine after licensure in the United States: experience from reports to the vaccine adverse event reporting system, 1995\u20132005","volume":"197","author":"Chaves","year":"2008","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2016.08.044_b0085","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/1096-9071(200008)61:4<497::AID-JMV13>3.0.CO;2-2","article-title":"Oka varicella vaccine is distinguishable from its parental virus in DNA sequence of open reading frame 62 and its transactivation activity","volume":"61","author":"Gomi","year":"2000","journal-title":"J Med Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2016.08.044_b0090","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1128\/JCM.42.4.1409-1413.2004","article-title":"Detection and genotyping of varicella-zoster virus by TaqMan allelic discrimination real-time PCR","volume":"42","author":"Campsall","year":"2004","journal-title":"J Clin Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2016.08.044_b0095","doi-asserted-by":"crossref","first-page":"E39","DOI":"10.1542\/peds.108.2.e39","article-title":"Disseminated vaccine strain varicella as the acquired immunodeficiency syndrome-defining illness in a previously undiagnosed child","volume":"108","author":"Kramer","year":"2001","journal-title":"Pediatrics"},{"issue":"9568","key":"10.1016\/j.vaccine.2016.08.044_b0100","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/S0140-6736(07)60567-4","article-title":"Varicella vaccination in a child with acute lymphoblastic leukaemia","volume":"369","author":"Schrauder","year":"2007","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.vaccine.2016.08.044_b0105","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1086\/378503","article-title":"Disseminated varicella infection due to the vaccine strain of varicella-zoster virus, in a patient with a novel deficiency in natural killer T cells","volume":"188","author":"Levy","year":"2003","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2016.08.044_b0110","doi-asserted-by":"crossref","first-page":"e1345","DOI":"10.1542\/peds.2004-1681","article-title":"Severe varicella caused by varicella-vaccine strain in a child with significant T-cell dysfunction","volume":"120","author":"Jean-Philippe","year":"2007","journal-title":"Pediatrics"},{"issue":"7","key":"10.1016\/j.vaccine.2016.08.044_b0115","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1086\/378502","article-title":"Development of resistance to acyclovir during chronic infection with the Oka vaccine strain of varicella-zoster virus, in an immunosuppressed child","volume":"188","author":"Levin","year":"2003","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2016.08.044_b0120","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1093\/infdis\/jir660","article-title":"Disseminated varicella infection caused by varicella vaccine strain in a child with low invariant natural killer T cells and diminished CD1d expression","volume":"204","author":"Banovic","year":"2011","journal-title":"J Infect Dis"},{"issue":"22","key":"10.1016\/j.vaccine.2016.08.044_b0125","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1056\/NEJM199111283252204","article-title":"The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia","volume":"325","author":"Hardy","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2016.08.044_b0130","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/978-1-4684-5853-4_6","article-title":"A live varicella vaccine","volume":"278","author":"Takahashi","year":"1990","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"10.1016\/j.vaccine.2016.08.044_b0135","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1128\/CMR.00031-09","article-title":"Impact of varicella vaccine on varicella-zoster virus dynamics","volume":"23","author":"Schmid","year":"2010","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"10.1016\/j.vaccine.2016.08.044_b0140","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/INF.0b013e318273e43d","article-title":"Fatal wild-type varicella-zoster virus encephalitis without a rash in a vaccinated child","volume":"32","author":"Ibraheem","year":"2013","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"10.1016\/j.vaccine.2016.08.044_b0145","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/infdis\/160.3.535","article-title":"Herpes zoster in an adult recipient of live attenuated varicella vaccine","volume":"160","author":"Hammerschlag","year":"1989","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16307290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16307290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T02:14:10Z","timestamp":1657246450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16307290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":29,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0264410X16307290"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.08.044","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety profile of the varicella vaccine (Oka vaccine strain) based on reported cases from 2005 to 2015 in Japan","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.08.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}